Basin Genomics

Basin Genomics was a private biotechnology and health diagnostics company developing molecular diagnostic tests for human papillomavirus-associated cancers. The company focused on improving early detection of HPV infection and precancerous cellular changes, with applications spanning cervical, oral, and head and neck cancers. It described itself as a Department of Defense spinout and promoted a platform called Molecular Pap designed to be accurate, automatable, low cost, and compatible with self-sampling approaches. Public company-directory and startup-database sources indicate the business was founded in 2018, led by founder and CEO Jenna Baker, participated in IndieBio, and later became inactive or closed. The company appears to have remained at an early commercial and development stage rather than advancing a therapeutic drug pipeline.